Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Spitzweg

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Human Gene Therapy|June 8, 2011
Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activationA Schäfer, A Pahnke, D Schaffert, et al.
Gene Therapy|November 9, 2007
Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinomaM J Willhauck, B R Sharif Samani, K Klutz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Biodistribution and first clinical results of <sup>18</sup>F-SiFAlin-TATE PET: a novel <sup>18</sup>F-labeled somatostatin analog for imaging of neuroendocrine tumorsHarun Ilhan, S Lindner, A Todica, et al.
European Radiology|May 20, 2024
Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATER Ebner, A Lohse, M P Fabritius, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 28, 2023
Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumorsM P Fabritius, V Soltani, C C Cyran, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Human Gene Therapy|June 8, 2011
Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activationA Schäfer, A Pahnke, D Schaffert, et al.
Gene Therapy|November 9, 2007
Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinomaM J Willhauck, B R Sharif Samani, K Klutz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Biodistribution and first clinical results of <sup>18</sup>F-SiFAlin-TATE PET: a novel <sup>18</sup>F-labeled somatostatin analog for imaging of neuroendocrine tumorsHarun Ilhan, S Lindner, A Todica, et al.
European Radiology|May 20, 2024
Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATER Ebner, A Lohse, M P Fabritius, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 28, 2023
Diagnostic accuracy of SSR-PET/CT compared to histopathology in the identification of liver metastases from well-differentiated neuroendocrine tumorsM P Fabritius, V Soltani, C C Cyran, et al.
Pageof 7